ATE261431T1 - Kristalline form von (s)-2-ethoxy-3-4-(2-4- methansulfonyloxyphenyl-ethoxy)phenyl)propansäu e - Google Patents

Kristalline form von (s)-2-ethoxy-3-4-(2-4- methansulfonyloxyphenyl-ethoxy)phenyl)propansäu e

Info

Publication number
ATE261431T1
ATE261431T1 AT00983618T AT00983618T ATE261431T1 AT E261431 T1 ATE261431 T1 AT E261431T1 AT 00983618 T AT00983618 T AT 00983618T AT 00983618 T AT00983618 T AT 00983618T AT E261431 T1 ATE261431 T1 AT E261431T1
Authority
AT
Austria
Prior art keywords
ethoxy
methanesulfonyloxyphenyl
phenyl
crystalline form
propane acid
Prior art date
Application number
AT00983618T
Other languages
English (en)
Inventor
Maria Boije
Karol Horvath
Tord Inghardt
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9904416A external-priority patent/SE9904416D0/xx
Priority claimed from SE0001187A external-priority patent/SE0001187D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE261431T1 publication Critical patent/ATE261431T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
AT00983618T 1999-12-03 2000-11-29 Kristalline form von (s)-2-ethoxy-3-4-(2-4- methansulfonyloxyphenyl-ethoxy)phenyl)propansäu e ATE261431T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9904416A SE9904416D0 (sv) 1999-12-03 1999-12-03 Crystalline form
SE0001187A SE0001187D0 (sv) 2000-04-03 2000-04-03 Crystalline form
PCT/SE2000/002384 WO2001040171A1 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid

Publications (1)

Publication Number Publication Date
ATE261431T1 true ATE261431T1 (de) 2004-03-15

Family

ID=26655058

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00983618T ATE261431T1 (de) 1999-12-03 2000-11-29 Kristalline form von (s)-2-ethoxy-3-4-(2-4- methansulfonyloxyphenyl-ethoxy)phenyl)propansäu e

Country Status (30)

Country Link
US (1) US6531622B1 (de)
EP (1) EP1237855B1 (de)
JP (1) JP2003515582A (de)
KR (1) KR20030029040A (de)
CN (1) CN1198799C (de)
AR (1) AR029412A1 (de)
AT (1) ATE261431T1 (de)
AU (1) AU773777B2 (de)
BR (1) BR0016131A (de)
CA (1) CA2392038A1 (de)
CO (1) CO5271735A1 (de)
CZ (1) CZ20021902A3 (de)
DE (1) DE60008921T2 (de)
DK (1) DK1237855T3 (de)
EE (1) EE200200278A (de)
ES (1) ES2215769T3 (de)
HK (1) HK1048980A1 (de)
HU (1) HUP0203444A3 (de)
IL (1) IL149577A0 (de)
IS (1) IS6400A (de)
MX (1) MXPA02005327A (de)
MY (1) MY135954A (de)
NO (1) NO20022598L (de)
NZ (1) NZ518925A (de)
PL (1) PL357118A1 (de)
PT (1) PT1237855E (de)
RU (1) RU2268880C2 (de)
SK (1) SK7652002A3 (de)
TR (1) TR200401333T4 (de)
WO (1) WO2001040171A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
AU752059B2 (en) 1997-10-27 2002-09-05 Dr. Reddy's Laboratories Limited Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
CN100376560C (zh) 1997-10-27 2008-03-26 雷迪实验室有限公司 新型三环化合物和其作为药物的用途;其制备方法和包含该化合物的药物组合物
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
AU1198699A (en) 1997-10-27 1999-04-23 Dr. Reddy's Research Foundation Novel heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them
CN1323300A (zh) 1998-10-29 2001-11-21 雷迪研究基金会 制备新的抗糖尿病剂的改进方法
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
US7084177B2 (en) * 1999-12-03 2006-08-01 Astrazeneca Ab Comminuted form of(S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid
US6897199B2 (en) 2001-02-05 2005-05-24 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
CA2546601A1 (en) 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
EP1586573B1 (de) 2004-04-01 2007-02-07 Sanofi-Aventis Deutschland GmbH Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
DE102004035034A1 (de) * 2004-07-20 2006-02-16 Degussa Ag Racematspaltung von p-Hydroxyphenyl-2-alkoxy-propionsäuren
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues

Also Published As

Publication number Publication date
DE60008921T2 (de) 2005-01-20
AR029412A1 (es) 2003-06-25
ES2215769T3 (es) 2004-10-16
RU2268880C2 (ru) 2006-01-27
NO20022598D0 (no) 2002-05-31
AU2035001A (en) 2001-06-12
MXPA02005327A (es) 2002-12-06
HUP0203444A2 (hu) 2003-02-28
IL149577A0 (en) 2002-11-10
MY135954A (en) 2008-07-31
EE200200278A (et) 2003-06-16
NO20022598L (no) 2002-05-31
US6531622B1 (en) 2003-03-11
EP1237855B1 (de) 2004-03-10
RU2002113450A (ru) 2004-01-10
JP2003515582A (ja) 2003-05-07
WO2001040171A1 (en) 2001-06-07
BR0016131A (pt) 2002-08-20
DK1237855T3 (da) 2004-06-14
IS6400A (is) 2002-05-28
AU773777B2 (en) 2004-06-03
PL357118A1 (en) 2004-07-12
CZ20021902A3 (cs) 2002-11-13
PT1237855E (pt) 2004-06-30
SK7652002A3 (en) 2002-11-06
CN1198799C (zh) 2005-04-27
NZ518925A (en) 2004-06-25
EP1237855A1 (de) 2002-09-11
CN1409701A (zh) 2003-04-09
DE60008921D1 (en) 2004-04-15
HK1048980A1 (en) 2003-04-25
CO5271735A1 (es) 2003-04-30
CA2392038A1 (en) 2001-06-07
KR20030029040A (ko) 2003-04-11
TR200401333T4 (tr) 2004-08-23
HUP0203444A3 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
ATE261431T1 (de) Kristalline form von (s)-2-ethoxy-3-4-(2-4- methansulfonyloxyphenyl-ethoxy)phenyl)propansäu e
DE69941116D1 (de) G von gdf-8
DE69927969D1 (de) Kontrollierte freisetzung von liponsäure
DE69918278D1 (de) Substituierte indolalkansäure
DK1261585T3 (da) Substituerede indol-Mannichbaser
EE200000720A (et) Uus 3-arüül-2-hüdroksüpropaanhappe derivaat (I)
DE60037213D1 (de) Verwendung von Reinigungsgas
ATE353891T1 (de) Ditosylatsalze von chinazolinverbindungen
DE60217126D1 (de) Herstellung von aminopyrimidinverbindungen
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
ATE419231T1 (de) Mono-substituierte 3-propyl-gamma- aminobuttersäure
EE200100135A (et) EtO2C-CH2-(R)Cgl-Aze-Pab-OH kristalsed vormid
ATE251131T1 (de) Feinteilige form von (s)-2-ethoxy -3- 4-(2- 4- methansulfonyloxyphenyl ethoxy)phenyl)propansäure
DE60019960D1 (de) Herstellung von isobutencopolymere
DE60107074D1 (de) Kristallin form ii von cabergolin
ATE339438T1 (de) Substanziell kristalline form von melagatran
DE60142051D1 (de) Herstellung von perfluorolefinen
DE69913556D1 (de) Herstellung von aminen
DE60006799D1 (de) Oralverabreichbare lösung von prucaloprid
DE60026931D1 (de) Ausrichtung von Ausdrucken
DE69908951D1 (de) Kristallformen von osanetant
DE60016608D1 (de) Herstellung von sulfonylimin-verbindungen
EE200100381A (et) Morfolinobensamiidi uued soolad
EE200100017A (et) N-tert-butüülhüdroksüülamiini uued soolad
DE69940563D1 (de) Wachstum von aluminium-einkristallen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1237855

Country of ref document: EP

REN Ceased due to non-payment of the annual fee